Laparoscopic closure of the pouch of Douglas by a peritoneal running suture. A minimally invasive and prosthetic-free technique to prevent excessive dose delivery to the small bowel during pelvic irradiation for prostate cancer.

Douglas’ pouch Laparoscopy Prostatic neoplasm Radiation-induced enteritis Radiotherapy Small bowel

Journal

Clinical and translational radiation oncology
ISSN: 2405-6308
Titre abrégé: Clin Transl Radiat Oncol
Pays: Ireland
ID NLM: 101713416

Informations de publication

Date de publication:
Jan 2021
Historique:
received: 01 09 2020
revised: 23 11 2020
accepted: 26 11 2020
entrez: 14 12 2020
pubmed: 15 12 2020
medline: 15 12 2020
Statut: epublish

Résumé

Prostate radiotherapy relies on the delivery of high doses that can be obstructed when a small bowel loop descends in the pelvis. We present a laparoscopic minimally invasive prosthetic-free technique closing the Douglas' pouch with a peritoneal running suture to cordon off the bowel from the pelvis and hence allow optimal irradiation. Prostate cancer patients referred for radiotherapy and whose planning-CT revealed a bowel loop trapped in the pelvis were proposed the procedure, followed by a new planning-CT. This proof-of-concept study reports postoperative follow-up and dosimetric benefits. The procedure was performed in ten patients (2016-2020) as a same-day surgery for nine. Median operative time was 34 min (range 22-50) and no relevant intraoperative complication occurred. The third patient of the series presented a small bowel hernia through the peritoneal suture at the 15th postoperative day requiring a laparotomic desincarceration without major consequences. Regarding the small bowel, median D1cc (dose to 1 cc) was 65.5 Gy and 55.5 Gy (p = 0.005) before and after procedure. Median V60 (volume receiving ≥60 Gy) was 10.2 cc and 0.0 cc (p = 0.005). In the immediate vicinity of the small bowel (5 mm), median D1cc was 68.3 Gy and 57.7 Gy (p = 0.005). Radiotherapy was safely delivered to all patients. Laparoscopic closure of the Douglas' pouch by a peritoneal suture is an efficient technique to cordon off inconvenient ectopic small bowel loops. It prevents excessive bowel irradiation and hence facilitates curative prostate radiotherapy. The technique could be applied to other pelvic malignancies.

Sections du résumé

BACKGROUND AND PURPOSE OBJECTIVE
Prostate radiotherapy relies on the delivery of high doses that can be obstructed when a small bowel loop descends in the pelvis. We present a laparoscopic minimally invasive prosthetic-free technique closing the Douglas' pouch with a peritoneal running suture to cordon off the bowel from the pelvis and hence allow optimal irradiation.
MATERIALS AND METHODS METHODS
Prostate cancer patients referred for radiotherapy and whose planning-CT revealed a bowel loop trapped in the pelvis were proposed the procedure, followed by a new planning-CT. This proof-of-concept study reports postoperative follow-up and dosimetric benefits.
RESULTS RESULTS
The procedure was performed in ten patients (2016-2020) as a same-day surgery for nine. Median operative time was 34 min (range 22-50) and no relevant intraoperative complication occurred. The third patient of the series presented a small bowel hernia through the peritoneal suture at the 15th postoperative day requiring a laparotomic desincarceration without major consequences. Regarding the small bowel, median D1cc (dose to 1 cc) was 65.5 Gy and 55.5 Gy (p = 0.005) before and after procedure. Median V60 (volume receiving ≥60 Gy) was 10.2 cc and 0.0 cc (p = 0.005). In the immediate vicinity of the small bowel (5 mm), median D1cc was 68.3 Gy and 57.7 Gy (p = 0.005). Radiotherapy was safely delivered to all patients.
CONCLUSION CONCLUSIONS
Laparoscopic closure of the Douglas' pouch by a peritoneal suture is an efficient technique to cordon off inconvenient ectopic small bowel loops. It prevents excessive bowel irradiation and hence facilitates curative prostate radiotherapy. The technique could be applied to other pelvic malignancies.

Identifiants

pubmed: 33313426
doi: 10.1016/j.ctro.2020.11.015
pii: S2405-6308(20)30102-6
pmc: PMC7721662
doi:

Types de publication

Journal Article

Langues

eng

Pagination

71-78

Informations de copyright

© 2020 The Author(s).

Déclaration de conflit d'intérêts

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

Am J Clin Oncol. 1988 Feb;11(1):25-33
pubmed: 2829614
Clin Oncol (R Coll Radiol). 2020 Feb;32(2):e60-e66
pubmed: 31607614
Lancet. 1988 Dec 10;2(8624):1341-2
pubmed: 2904055
Surg Gynecol Obstet. 1983 Sep;157(3):269-71
pubmed: 6612575
Radiother Oncol. 2016 Nov;121(2):199-203
pubmed: 27863963
Radiother Oncol. 2003 Oct;69(1):99-105
pubmed: 14597362
Int J Radiat Oncol Biol Phys. 2012 Jul 1;83(3):e353-62
pubmed: 22483697
Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3 Suppl):S10-9
pubmed: 20171502
Int J Radiat Oncol Biol Phys. 1991 May 15;21(1):109-22
pubmed: 2032882
Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3 Suppl):S101-7
pubmed: 20171503
Strahlenther Onkol. 2012 Jan;188(1):97-9
pubmed: 22234506
Oncology (Williston Park). 1998 Jan;12(1):51-4; discussion 54, 60, 62, passim
pubmed: 9474587
Can Urol Assoc J. 2011 Oct;5(5):342-8
pubmed: 22031616
Strahlenther Onkol. 2005 Sep;181(9):601-5
pubmed: 16170488
Pathol Oncol Res. 2019 Jul;25(3):995-1002
pubmed: 29882196
Ann Surg. 2019 Jan;269(1):30-36
pubmed: 30222598
Radiother Oncol. 2004 Jan;70(1):37-44
pubmed: 15036850
Ther Adv Chronic Dis. 2014 Jan;5(1):15-29
pubmed: 24381725
Radiother Oncol. 2003 Nov;69(2):201-7
pubmed: 14643959
J Laparoendosc Adv Surg Tech A. 2015 Jan;25(1):77-80
pubmed: 25531859
Cancer. 1991 Dec 15;68(12):2545-9
pubmed: 1657360
Int J Radiat Oncol Biol Phys. 2017 Mar 15;97(4):718-721
pubmed: 28244406
Adv Radiat Oncol. 2017 Sep 08;2(4):615-623
pubmed: 29204529
Radiat Oncol. 2018 Apr 17;13(1):70
pubmed: 29665832
Int J Radiat Oncol Biol Phys. 1986 Sep;12(9):1565-73
pubmed: 3759581
Int J Radiat Oncol Biol Phys. 2009 Jun 1;74(2):383-7
pubmed: 18947938
Surg Endosc. 2014 Sep;28(9):2713-8
pubmed: 24789127
Int J Surg. 2015 Nov;23(Pt A):62-7
pubmed: 26369863
JAMA. 2016 Oct 18;316(15):1575-1582
pubmed: 27750295
Gynecol Oncol. 1988 Mar;29(3):283-9
pubmed: 3345950
J Cancer Res Clin Oncol. 2015 Jun;141(6):1063-71
pubmed: 25173623
Eur J Surg Oncol. 2009 Apr;35(4):348-51
pubmed: 18358678
Dis Colon Rectum. 2008 Sep;51(9):1403-7
pubmed: 18418651
Radiat Oncol. 2011 May 14;6:47
pubmed: 21569584

Auteurs

Maxime Loo (M)

Department of Radiation Oncology, Institut Universitaire du Cancer de Toulouse, 1, avenue Irène Joliot-Curie, 31100 Toulouse, France.

Carlos Martinez-Gomez (C)

Department of Surgical Oncology, Institut Universitaire du Cancer de Toulouse, 1, avenue Irène Joliot-Curie, 31100 Toulouse, France.
INSERM CRCT Team 1, Tumor Immunology and Immunotherapy, 2 Avenue Hubert Curien, 31100 Toulouse, France.

Jonathan Khalifa (J)

Department of Radiation Oncology, Institut Universitaire du Cancer de Toulouse, 1, avenue Irène Joliot-Curie, 31100 Toulouse, France.
INSERM CRCT Team 1, Tumor Immunology and Immunotherapy, 2 Avenue Hubert Curien, 31100 Toulouse, France.

Martina-Aida Angeles (MA)

Department of Surgical Oncology, Institut Universitaire du Cancer de Toulouse, 1, avenue Irène Joliot-Curie, 31100 Toulouse, France.

Ciprian Chira (C)

Department of Radiation Oncology, Institut Universitaire du Cancer de Toulouse, 1, avenue Irène Joliot-Curie, 31100 Toulouse, France.

Lucie Piram (L)

Department of Radiation Oncology, Institut Universitaire du Cancer de Toulouse, 1, avenue Irène Joliot-Curie, 31100 Toulouse, France.

Elodie Martin (E)

Department of Biostatistics, Institut Universitaire du Cancer de Toulouse, 1, avenue Irène Joliot-Curie, 31100 Toulouse, France.

Bernard Malavaud (B)

Department of Urology, Institut Universitaire du Cancer de Toulouse, 1, avenue Irène Joliot-Curie, 31100 Toulouse, France.

Gwenaël Ferron (G)

Department of Surgical Oncology, Institut Universitaire du Cancer de Toulouse, 1, avenue Irène Joliot-Curie, 31100 Toulouse, France.
INSERM CRCT Team 19, ONCOSARC-Oncogenesis of Sarcomas, 2 Avenue Hubert Curien, 31100 Toulouse, France.

Pierre Graff-Cailleaud (P)

Department of Radiation Oncology, Institut Universitaire du Cancer de Toulouse, 1, avenue Irène Joliot-Curie, 31100 Toulouse, France.
Department of Radiation Oncology, Institut Curie, 25 rue d'Ulm, 75005 Paris.

Classifications MeSH